ASAS Criteria for Axial Spondyloarthritis (Axial SpA)
Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial SpA in patients with chronic back pain ≥3 months onset age <45 years. Includes radiographic (AS) and non-radiographic axial SpA.
Score interpretation
Neither imaging nor clinical arm criteria met
→ Consider alternative diagnoses; if high clinical suspicion, repeat MRI after 3–6 months; rheumatology referral for specialist assessment; NSAID trial for symptomatic relief
Apply ASAS arm criteria: Imaging arm (sacroiliitis + ≥1 SpA feature) OR Clinical arm (HLA-B27 + ≥2 SpA features)
→ If imaging arm positive: axial SpA diagnosed; MRI or X-ray confirm sacroiliitis. If clinical arm positive: non-radiographic axial SpA. Management: NSAIDs, physiotherapy; if inadequate response: anti-TNF or IL-17 inhibitor (secukinumab/ixekizumab); consider referral to SpA specialist
Interpretation bands for the ASAS Axial SpA. Apply clinical judgement and local guidance.
References
- Rudwaleit M et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis. Ann Rheum Dis. 2009;68(6):777–783.
Related
Curated clinical cross-links plus same-class fallbacks.
- Dapsone · Anti-inflammatory / Antimicrobial
- Colchicine · Anti-inflammatory — Neutrophilic Dermatoses / Vasculitis
- Methoxyflurane · Inhaled Analgesic — Acute Pain
- Diclofenac · Non-Steroidal Anti-Inflammatory Drug (NSAID)
- Colchicine (Acute Gout) · Anti-Inflammatory (Microtubule Inhibitor)
- Diclofenac · NSAID (Non-Steroidal Anti-Inflammatory Drug)
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.